REPORT ID 20671

United States Docetaxel Market Report 2019

Publish Date
2019
Pages
106
Format
Electronic (PDF)

The global Docetaxel market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of  XX% between 2019 and 2025. 

United States plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%. 

This report studies the Docetaxel development status and future trend in United States, focuses on top players in United States, also splits Docetaxel by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in United States market include Sun Pharmaceutical Industries, Pfizer, Accord Healthcare, Sandoz, Jiangsu Hengrui Medicine, Actavis, Teva, Dr. Reddy, Sanofi, Eagle Pharmaceuticals

Geographically, this report splits the United States market into six regions, 
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest

On the basis on the end users/applications, this report covers 
Antineoplastics 
			   
United States Docetaxel Market  Report 2019
1 Methodology/Research Approach
1.1 Research Programs/Design
1.2 Market Size Estimation
1.3 Market Breakdown and Data Triangulation
2 Data Source
2.1 Secondary Sources
2.2 Primary Sources
3 Disclaimer
1 Docetaxel Overview
1.1 Product Overview and Scope of Docetaxel
1.2 Classification of Docetaxel by Product Category
1.2.1 United States Docetaxel Sales (K Units) Comparison by Types ( 2014-2024)
1.2.2 United States Docetaxel Sales (K Units) Market Share by Types (Product Category)  in 2018
1.3 United States Docetaxel Market by Applications/End Users
1.3.1 United States Docetaxel Sales (K Units) and Market Share Comparison by Applications ( 2014-2024)
1.4 United States Docetaxel Market by Regions
1.4.1 United States Docetaxel Market Size (Million USD) Comparison by Regions ( 2014-2024)
1.4.2 The West Docetaxel Status and Prospect ( 2014-2024)
1.4.3 Southwest Docetaxel Status and Prospect ( 2014-2024)
1.4.4 The Middle Atlantic Docetaxel Status and Prospect ( 2014-2024)
1.4.5 New England Docetaxel Status and Prospect ( 2014-2024)
1.4.6 The South of US Docetaxel Status and Prospect ( 2014-2024)
1.4.7 The Midwest Docetaxel Status and Prospect ( 2014-2024)
1.5 United States Market Size (Sales and Revenue) of Docetaxel ( 2014-2024)
1.5.1 United States Docetaxel Sales (K Units) and Growth Rate (%) ( 2014-2024)
1.5.2 United States Docetaxel Revenue (Million USD) and Growth Rate ( 2014-2024)
2 United States Docetaxel Market Competition by Players/Manufacturers
2.1 United States Docetaxel Sales and Market Share of Key Players/Manufacturers ( 2014-2019)
2.2 United States Docetaxel Revenue and Share by Players/Manufacturers ( 2014-2019)
2.3 United States Docetaxel Average Price (USD/Unit) by Players/Manufacturers ( 2014-2019)
2.4 United States Docetaxel Market Competitive Situation and Trends
2.4.1 United States Docetaxel Market Concentration Rate
2.4.2 United States Docetaxel Market Share of Top 3 and Top 5 Players/Manufacturers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Manufacturers Docetaxel Manufacturing Base Distribution, Sales Area, Product Types
3 United States Docetaxel Sales and Revenue by Regions ( 2014-2019)
3.1 United States Docetaxel Sales (K Units) and Market Share by Regions ( 2014-2019)
3.2 United States Docetaxel Revenue (Million USD) and Market Share by Regions ( 2014-2019)
3.3 United States Docetaxel Price (USD/Unit) by Regions ( 2014-2019)
4 United States Docetaxel Sales and Revenue by Type/ Product Category ( 2014-2019)
4.1 United States Docetaxel Sales (K Units) and Market Share by Type/ Product Category ( 2014-2019)
4.2 United States Docetaxel Revenue (Million USD) and Market Share by Type ( 2014-2019)
4.3 United States Docetaxel Price (USD/Unit) by Type ( 2014-2019)
4.4 United States Docetaxel Sales Growth Rate (%) (%) by Type ( 2014-2019)
5 United States Docetaxel Sales by Application ( 2014-2019)
5.1 United States Docetaxel Sales (K Units) and Market Share by Applications ( 2014-2019)
5.2 United States Docetaxel Sales Growth Rate (%) (%) by Applications ( 2014-2019)
5.3 Market Drivers and Opportunities
6 United States Docetaxel Players/Manufacturers Profiles and Sales Data
6.1 Sun Pharmaceutical Industries
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Docetaxel Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Sun Pharmaceutical Industries Docetaxel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) ( 2014-2019)
6.1.4 Main Business/Business Overview
6.2 Pfizer
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Docetaxel Product Category, Application and Specification
6.2.2.1  Product A
6.2.2.2  Product B
6.2.3 Pfizer Docetaxel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) ( 2014-2019)
6.2.4 Main Business/Business Overview
6.3 Accord Healthcare
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Docetaxel Product Category, Application and Specification
6.3.2.1  Product A
6.3.2.2  Product B
6.3.3 Accord Healthcare Docetaxel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) ( 2014-2019)
6.3.4 Main Business/Business Overview
6.4 Sandoz
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Docetaxel Product Category, Application and Specification
6.4.2.1  Product A
6.4.2.2  Product B
6.4.3 Sandoz Docetaxel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) ( 2014-2019)
6.4.4 Main Business/Business Overview
6.5 Jiangsu Hengrui Medicine
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Docetaxel Product Category, Application and Specification
6.5.2.1  Product A
6.5.2.2  Product B
6.5.3 Jiangsu Hengrui Medicine Docetaxel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) ( 2014-2019)
6.5.4 Main Business/Business Overview
6.6 Actavis
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Docetaxel Product Category, Application and Specification
6.6.2.1  Product A
6.6.2.2  Product B
6.6.3 Actavis Docetaxel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) ( 2014-2019)
6.6.4 Main Business/Business Overview
6.7 Teva
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Docetaxel Product Category, Application and Specification
6.7.2.1  Product A
6.7.2.2  Product B
6.7.3 Teva Docetaxel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) ( 2014-2019)
6.7.4 Main Business/Business Overview
6.8 Dr. Reddy
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Docetaxel Product Category, Application and Specification
6.8.2.1  Product A
6.8.2.2  Product B
6.8.3 Dr. Reddy Docetaxel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) ( 2014-2019)
6.8.4 Main Business/Business Overview
6.9 Sanofi
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Docetaxel Product Category, Application and Specification
6.9.2.1  Product A
6.9.2.2  Product B
6.9.3 Sanofi Docetaxel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) ( 2014-2019)
6.9.4 Main Business/Business Overview
6.10 Eagle Pharmaceuticals
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Docetaxel Product Category, Application and Specification
6.10.2.1  Product A
6.10.2.2  Product B
6.10.3 Eagle Pharmaceuticals Docetaxel Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) ( 2014-2019)
6.10.4 Main Business/Business Overview
7 Docetaxel Manufacturing Cost Analysis
7.1 Docetaxel Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Docetaxel
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Docetaxel Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Docetaxel Major Players/Manufacturers in 2015
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Docetaxel Market Size (Sales and Revenue) Forecast ( 2019-2025)
11.1 United States Docetaxel Sales (K Units), Revenue (Million USD) Forecast ( 2019-2025)
11.2 United States Docetaxel Sales (K Units) Forecast by Type ( 2019-2025)
11.3 United States Docetaxel Sales (K Units) Forecast by Application ( 2019-2025)
11.4 United States Docetaxel Sales (K Units) Forecast by Regions ( 2019-2025)
12 Research Findings and Conclusion